Haus Bioceuticals, Inc Oklahoma City, OK Aug 2010 to Jun 2012 Vice PresidentCrescendo Bioscience, Inc Oklahoma City, OK May 2008 to Oct 2011 Senior DirectorRiley Genomics, Inc Oklahoma City, OK May 2005 to May 2008 Vice President of OperationsRiley Genomics, Inc Oklahoma City, OK Sep 2002 to Sep 2007 Secretary, Board of DirectorsManager of Post-PCR Operations National Genetics Institute, LA, CA Aug 2002 to Apr 2005Prometheus Laboratories San Diego, CA Oct 1999 to May 2002 Project ManagerPrometheus Laboratories San Diego, CA Apr 1999 to May 2002 Senior Research ScientistDepartment of Pathology
Mar 1999 to May 2002 Visiting Assistant ResearcherDepartment of Pathology
Nov 1995 to Oct 1999 Postdoctoral ResearcherXOMA Corporation Santa Monica, CA Oct 1993 to Apr 1995 Postdoctoral ResearcherDepartment of Biological Chemistry
Sep 1988 to Dec 1993 Graduate StudentHana Biologics Alameda, CA Oct 1986 to Aug 1988 Research AssociateWaisbren Research Milwaukee, WI May 1984 to Jun 1985 Research AssociateUniversity of Wisconsin Milwaukee, WI May 1983 to May 1984 purposes. - Senior Research Project
Education:
University of California Los Angeles, CA Sep 1988 to Dec 1993 Ph.D. in Biological ChemistryUniversity of Wisconsin Milwaukee, WI Jan 1982 to May 1984 B.S. in Molecular BiologyWashington University St. Louis, MO Sep 1979 to Dec 1981 Chemical Engineering
Litigation Compliance & Environmental Health & Safety Audits Mergers & Acquisitions Real Estate Insurance Coverage Investigations & White Collar Defense Environmental Litigation Water Rights Worker Safety & Health Cleantech Oil & Gas Admin/Govt/Reg Law Environmental Law Natural Resources & Energy-Mining Law Government Administration
Jonathan Braun - Tarzana CA Christopher Sutton - Encinitas CA
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
C07H 2104
US Classification:
536 2432, 536 237, 4241901
Abstract:
The present invention provides nucleic acid and amino acid sequence of the novel I-1 and I-2 polypeptides, which are associated with human inflammatory bowel disease (IBD). Methods of diagnosing and treating inflammatory bowel disease using the IBD-associated I-1 and I-2 antigens also are provided.
Diagnosis, Prevention And Treatment Of Crohn's Disease Using The Ompc Antigen
The present invention provides a method of diagnosing Crohn's disease in a subject by determining the presence or absence of IgA anti-OmpC antibodies in the subject, where the presence of the IgA anti-OmpC antibodies indicates that the subject has Crohn's disease.
Antibody Materials For An Ibd-Associated Polypeptide
Jonathan Braun - Tarzana CA, US Christopher Sutton - Encinitas CA, US
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
C07K 16/12
US Classification:
5303895, 5303884, 5303873
Abstract:
The present invention provides nucleic acid and amino acid sequence of the novel I-1 and I-2 polypeptides, which are associated with human inflammatory bowel disease (IBD). Methods of diagnosing and treating inflammatory bowel disease using the IBD-associated I-1 and I-2 antigens also are provided.
Diagnosis, Prevention And Treatment Of Crohn's Disease Using The Ompc Antigen
The present invention provides a method of diagnosing Crohn's disease in a subject by determining the presence or absence or IgA anti-OmpC antibodies in the subject, where the presence of the IgA anti-OmpC antibodies indicates that the subject has Crohn's disease.
Diagnosis, Prevention And Treatment Of Crohn's Disease Using The Ompc Antigen
The present invention provides a method of diagnosing Crohn's disease in a subject by determining the presence or absence or IgA anti-OmpC antibodies in the subject, where the presence of the IgA anti-OmpC antibodies indicates that the subject has Crohn's disease.
Diagnosis, Prevention And Treatment Of Crohn's Disease Using The Ompc Antigen
The present invention provides a method of diagnosing Crohn's disease in a subject by determining the presence or absence or IgA anti-OmpC antibodies in the subject, where the presence of the IgA anti-OmpC antibodies indicates that the subject has Crohn's disease.
Ibd-Associated Microbial Antigens And Methods Of Using Same
Jonathan Braun - Tarzana CA Christopher Sutton - Encinitas CA
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
A01K 3900 A01K 3938 C07K 1600 C07K 1700 C07K 500
US Classification:
4241851
Abstract:
The present invention provides nucleic acid and amino acid sequence of the novel I-1 and I-2 polypeptides, which are associated with human inflammatory bowel disease (IBD). Methods of diagnosing and treating inflammatory bowel disease using the IBD-associated I-1 and I-2 antigens also are provided.
Jonathan Braun - Tarzana CA Christopher Sutton - Encinitas CA
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
C07H 2104
US Classification:
536 237
Abstract:
The present invention provides nucleic acid and amino acid sequence of the novel I-1 and I-2 polypeptides, which are associated with human inflammatory bowel disease (IBD). Methods of diagnosing and treating inflammatory bowel disease using the IBD-associated I-1 and I-2 antigens also are provided.
Name / Title
Company / Classification
Phones & Addresses
Christopher P. Sutton Chief Executive Offi, President
Coast to Coast Financial Solutions
Christopher Lee Sutton
MKF SOLUTIONS, LLC
Christopher Sutton General Partner
Clover Global Solutions Staffing and Recruiting
16225 Park 10 Pl SUITE 420, Houston, TX 77084 200 Westlake Park Blvd, Houston, TX 77079 4 Centerpointe Dr, Buena Park, CA 90623 2819945900
The subsidies to billionaires are over, said Christopher Sutton, a Pasadena attorney who has opposed redevelopment agencies for years. He filed a friend of the court brief opposing redevelopment agencies.
Date: Dec 30, 2011
Category: U.S.
Source: Google
Andy Murray, Maria Sharapova win titles in Ohio | Tennis
Australian cyclist Christopher Sutton of the Sky team won the second stage of the Spanish Vuelta and Daniele Bennati of Italy took the leader's jersey from Leopard Trek teammate Jakob Fuglsang of Denmark.